BIOM news

BiomX approved a reverse stock split converting 10 old shares into 1 new share, effective September 9, 2026. The amendment also reduces the Common Stock from 150 million to 80 million shares.

Biomerica intends to issue and sell securities in a private placement. This transaction indicates the company is seeking to raise capital.

Biomerica is divesting a 6% stake in Diagnosis S.A., a Poland-based medical products company, through a securities purchase agreement with multiple buyers at $6.35 per share. The transaction represents a partial exit from the company's international holdings and generates $500,000 in proceeds.